DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Hepion Pharma Shares Up 48% After Hours Following 8-K Filing That Showed Results From Expanded Study Of CRV431 For NASH Indicated Prevention Of Liver Fibrosis Was Greater Than 4 Other Leading NASH Candidates

Benzinga · 01/28/2020 22:55